| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.32 | 0.1 |